biotech · Dental Caries · Cystic Fibrosis · ARMP
Armata Pharmaceuticals
Armata Pharmaceuticals patent portfolio — 5 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Freehold, USA
- Founded
- 2018
- Employees
- 18
- Programs
- 9
- Drugs
- 0
- Patents
- 5
Armata Pharmaceuticals patents
5 pharmaceutical patents indexed for Armata Pharmaceuticals. 0 expire within 24 months.
Armata Pharmaceuticals has 5 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12268720
Bacteriophage for treatment and prevention of E. coli and B. fragilis infections
granted -
US 12239677
Therapeutic bacteriophage compositions for treating Staphylococcus infection
granted -
US 11654166
Therapeutic bacteriophage compositions for treating Staphylococcus infection
granted -
US 11253557
Therapeutic bacteriophage compositions
granted -
US 10517908
Therapeutic bacteriophage compositions
granted
Frequently asked questions
How many patents does Armata Pharmaceuticals have?
5 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Armata Pharmaceuticals patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.